STEM CELL CARTILAGE REGENERATION MARKET ANALYSIS

Stem Cell Cartilage Regeneration Market, by Stem Cell Type (Hematopoietic Stem Cells (HSCs), Pluripotent Stem Cells (iPSC/ESCs), Mesenchymal Stem Cells (MSCs)), by Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, Stem Cell Injections), By End User (Hospitals, Ambulatory Surgical Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Apr 2023
Code : CMI2448
Pages :154
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Global Stem Cell Cartilage Regeneration Market – Driver

Increasing the number of cartilage disorders such as osteoarthritis and destruction of articular cartilage is expected to drive the market over the forecast period. For instance, in August 2020, data was published in the NCBI, according to which currently 52.2 million Americans are diagnosed with arthritis, and this is estimated to rise to 78.4 million by 2040, for these disorders, the most common type is osteoarthritis (OA).

Global Stem Cell Cartilage Regeneration Market: Restraint

High cost of the cartilage surgeries

One of the major factors that hampering the growth of stem cell cartilage regeneration is the high cost of the surgeries, which cost around or the average cost of the knee replacement procedure is cost around US$ 16,000, which costliest for the average population